Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 1 - 30 of 324
1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
		European Medicines Agency's website: M-M-RVAXPRO - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: MabThera - EMA: EPAR PI Finnish Swedish
PL	Resepti	Macrosalb Medi-Radiopharma 2,5 mg valmisteyhdistelmä radioaktiivista lääkettä varten SPC 2023-03-21.docx
PL	Resepti	Madopar 100 mg-25 mg depotkapseli SPC 2022-01-04
PL	Resepti	Madopar 100 mg-25 mg, 200 mg-50 mg tablettti SPC 2022-01-04
PL	Resepti	Madopar Quick 100 mg-25 mg liukeneva tabletti SPC 2022-01-04
PL	Itsehoito	Magnesiamaito 82,5 mg-ml oraalisuspensio SPC 2021-06-08
PL	Itsehoito	Magnesium Diasporal 400 mg jauhe oraaliliuosta varten, annospussi SPC 2023-06-28
PL	Itsehoito	Magnesium Diasporal 400 mg rakeet, annospussi SPC 2023-06-28
PL	Resepti	MaitalonCont 0,02 mg- 3 mg tabletti, kalvopäällysteinen SPC 2017-12-04.doc
PL	Itsehoito	Makrogoli Orion 12 g jauhe oraaliliuosta varten, annospussi SPC 2021-08-18
PL	Itsehoito	Makrogoli Orion 6 g jauhe oraaliliuosta varten, annospussi SPC 2021-08-18
PL	Resepti	Malarone 250 mg- 100 mg tabletti, kalvopäällysteinen SPC 2023-05-01
PL	Itsehoito	Maltofer 100 mg purutabletit SPC 2023-07-17.docx
PL	Resepti	Maltofer 2,5 mg-tippa, tipat, liuos SPC 2023-07-06
PL	Itsehoito	Malvitona oraaliliuos SPC 2021-10-01
PL	Resepti	Mannitol Baxter Viaflo 150 mg-ml, infuusioneste, liuos SPC 2021-09-06
PL	Resepti	Mannitol Braun 150 mg-ml infuusioneste SPC 2020-03-13
PL	Resepti	Marbodin 10 mg tabletti, kalvopäällysteinen SPC 2021-05-14
PL	Resepti	Marbodin 20 mg tabletti, kalvopäällysteinen SPC 2021-05-14
PL	Resepti	Marcain Adrenalin 2.5 mg-ml+5 mikrog-ml, 5 mg-ml+5 mikrog-ml injektioneste, SPC 2022-12-13
PL	Resepti	Marevan 3 mg tabletti SPC 2024-07-01
PL	Resepti	Marevan Forte 5 mg tabletti SPC 2024-07-01
		European Medicines Agency's website: Marixino (ent. Maruxa) - EMA: EPAR PI Finnish Swedish
PL	Itsehoito	Marzine 50 mg tabletti SPC 2024-10-01
		European Medicines Agency's website: Matever - EMA: EPAR PI Finnish Swedish
PL	Resepti	Matrifen 12, 25, 50, 75, 100 mikrog-tunti depotlaastari SPC 2024-09-06
		European Medicines Agency's website: Mavenclad - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Maviret - EMA: EPAR PI Finnish Swedish
PL	Resepti	Maxalt 5 mg, 10 mg tabletti SPC 2024-05-07
1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >